High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort

References

• zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690–8.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, . Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048–56.
   PubMed Web of Science ®Google Scholar
• Insigna RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009;9:119–45.
   PubMedGoogle Scholar
• Vaccarella S, Franceschi S, Clifford GM, Touzé A, Hsu CC, de Sanjosé S, . Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in 4 continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010;19:2379–88.
   PubMed Web of Science ®Google Scholar
• Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytological abnormalities. J Natl Cancer Inst 2005;97:1066–71.
   PubMed Web of Science ®Google Scholar
• Onuki M, Matsumoto K, Satoh T, Oki A, Okada S, Minaguchi T, . Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci 2009;100:1312–6.
   PubMed Web of Science ®Google Scholar
• Girianelli VR, Silva GA, Thuler LC. Factor associated with the risk of progression to precursor lesions or cervical cancer in women with negative cytologic findings. Int J Gynaecol Obstet 2009;107:228–31.
   PubMed Web of Science ®Google Scholar
• Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariaggi P, . Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18–24: result at recruitment. BMC Infect Dis 2010;10:157.
   PubMedGoogle Scholar
• Louvanto K, Syrjänen K, Rintala M, Grénman S, Syrjänen S. Human papillomavirus (HPV) and other predictors of incident CIN among young mothers prospectively followed-up for 6 years in the Finnish Family HPV Study. Acta Obstet Gynecol Scand 2011;90:167–73.
   PubMedGoogle Scholar
• Collins S, Rollason TP, Young LS, Woodman CB. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer 2010;46:405–11.
   PubMed Web of Science ®Google Scholar
• Rintala M, Grénman S, Puranen M, Isolauri E, Ekblad U, Kero P, . Transmission of high risk HPV between parents and infants: a prospective HPV Family Study in Finland. J Clin Microbiol 2005;43:376–81.
   PubMed Web of Science ®Google Scholar
• Louvanto K, Rintala MA, Syrjänen K, Grénman SE, Syrjänen SM. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis 2010;202:436–44.
   PubMedGoogle Scholar
• Louvanto K, Syrjänen KJ, Rintala MA, Grénman SE, Syrjänen SM. Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish Family HPV Study. J Clin Microbiol 2010;48:2665–71.
   PubMedGoogle Scholar
• Snijders P, van den Brule A, Schrijnemakers H, Snow G, Meijer C, Walboomers J. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990;71:173–81.
   PubMed Web of Science ®Google Scholar
• Anttila M, Syrjänen S, Ji H, Saarikoski S, Syrjänen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol 1999;72:337–41.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Bravo I, Snijders P, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006;44:504–12.
   PubMed Web of Science ®Google Scholar
• Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886–91.
   PubMed Web of Science ®Google Scholar
• Waterboer T, Sehr P, Michael K, Franceschi S, Nieland J, Joos T, . Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem 2005;51:1845–53.
   PubMed Web of Science ®Google Scholar
• Syrjänen S, Waterboer T, Sarkola M, Michael K, Rintala M, Syrjänen K, . Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 2009;90:1515–26.
   PubMed Web of Science ®Google Scholar
• Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM. High risk human papillomavirus DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 2005;41:731–8.
   Google Scholar
• Lorinz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003;127:959–68.
   PubMedGoogle Scholar
• Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, . Persistent high-risk human papillomavirus (HPV) infections and other endpoint markers of progressive cervical disease among women prospectively followed-up in the NIS and LAMS cohorts. Int J Gynecol Cancer 2009;19:934–42.
   PubMedGoogle Scholar
• Syrjänen KJ. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated HPV. Eur J Obstet Gynecol Reprod Biol 1996;65:45–53.
   PubMed Web of Science ®Google Scholar
• Kataja V, Syrjänen S, Yliskoski M, Hippelïnen M, Väyrynen M, Saarikoski S, . Risk factors associated with cervical human papillomavirus (HPV) infections: a case–control study. Am J Epidemiol 1993;138:735–45.
   PubMedGoogle Scholar
• Sjoeborg KD, Tropé A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, et al . HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol 2010;118:29–34.
   PubMed Web of Science ®Google Scholar
• Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:1611–22.
   PubMed Web of Science ®Google Scholar
• Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Johansson BC, . New Independent States of the former Soviet Union Cohort Study Group. Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study. Cancer Epidemiol Biomarkers Prev 2007;16:17–22.
   PubMed Web of Science ®Google Scholar
• Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, . The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12: 485–90.
   PubMed Web of Science ®Google Scholar
• Syrjänen K, de Villiers EM, Saarikoski S, Castren O, Väyrynen M, Mäntyjärvi R, . Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet 1985;1:510–1.
   PubMedGoogle Scholar
• Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, . The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (H PV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072–9.
   PubMed Web of Science ®Google Scholar
• Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, . Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008;68:307–13.
   PubMed Web of Science ®Google Scholar
• Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real time PCR technique. J Clin Microbiol 2002;40:886–91.
   PubMed Web of Science ®Google Scholar
• Kulmala SM, Syrjänen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, . Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006;59:513–7.
   PubMed Web of Science ®Google Scholar
• Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, . Distribution and viral load of 8 oncogenic types of human papillomavirus (HPV) and HPV16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007;20:256–66.
   PubMedGoogle Scholar
• Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, . Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002;102:152–8.
   PubMed Web of Science ®Google Scholar
• Skjeldestad FE, Mehta V, Sings HL, Øvreness T, Turpin J, Su L, . Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics. Acta Obstet Gynecol 2008;87:81–8.
   PubMed Web of Science ®Google Scholar
• Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, . Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911–9.
   PubMed Web of Science ®Google Scholar
• Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, . Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 2002;359:1093–101.
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, . HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219–26.
   PubMed Web of Science ®Google Scholar
• Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, . Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort. Br J Cancer 2000;88:1565–72.
   Google Scholar
• Castellsagué X, Muñoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20–8.
   PubMedGoogle Scholar
• Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM, . Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005;191:731–28.
   PubMed Web of Science ®Google Scholar